Alpha Healthcare Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
17 Septiembre 2020 - 4:48PM
Alpha Healthcare Acquisition Corp. (the “Company”) announced today
that it priced its initial public offering of 10,000,000 units at
$10.00 per unit. The units will be listed on the Nasdaq Capital
Market (“Nasdaq”) and will begin trading tomorrow, Friday,
September 18, 2020, under the ticker symbol “AHACU”. Each unit
consists of one share of the Company’s Class A common stock and
one-half of one redeemable warrant, each whole warrant entitling
the holder thereof to purchase one share of Class A common stock at
a price of $11.50 per share. Only whole warrants are exercisable
and will trade. Once the securities comprising the units
begin separate trading, shares of the Class A common stock and
warrants are expected to be listed on Nasdaq under the symbols
“AHAC” and “AHACW,” respectively.
The Company is a blank check company formed for the purpose of
effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with
one or more businesses. While the Company may pursue an initial
business combination target in any business or industry, it intends
to focus its search on companies in the healthcare industry in the
United States. The Company is led by Chairman and Chief Executive
Officer, Rajiv Shukla, and Chief Financial Officer, Patrick A.
Sturgeon.
Oppenheimer & Co. Inc. is acting as the sole book running
manager for the offering and Northland Capital Markets is acting as
co-manager for the offering. The Company has granted the
underwriters a 45-day option to purchase up to an additional
1,500,000 units at the initial public offering price to cover
over-allotments, if any.
The offering is being made only by means of a prospectus. Copies
of the prospectus may be obtained, when available, from Oppenheimer
& Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad
Street, 26th Floor, New York, New York 10004, by telephone at (212)
667-8055, by fax at (212) 667-6140, or by email at
EquityProspectus@opco.com.
A registration statement relating to these securities has been
filed with, and declared effective by, the Securities and Exchange
Commission (“SEC”) on September 17, 2020. This press release
shall not constitute an offer to sell or the solicitation of an
offer to buy, nor shall there be any sale of these securities in
any state or jurisdiction in which such an offer, solicitation or
sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.
Northland Capital Markets is the trade name for certain capital
markets and investment banking divisions of Northland Securities,
Inc., Member FINRA and SIPC.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute
“forward-looking statements,” including with respect to the initial
public offering. No assurance can be given that the offering
discussed above will be completed on the terms described, or at
all. Forward-looking statements are subject to numerous conditions,
many of which are beyond the control of the Company, including
those set forth in the Risk Factors section of the Company’s
registration statement and preliminary prospectus for the offering
filed with the SEC. Copies are available on the SEC’s
website, www.sec.gov. The Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release, except as required by law.
Contact
Rajiv ShuklaAlpha Healthcare Acquisition Corp. (646)
494-3296info@alphaspac.com
Alpha Healthcare Acquisi... (NASDAQ:AHACU)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Alpha Healthcare Acquisi... (NASDAQ:AHACU)
Gráfica de Acción Histórica
De May 2023 a May 2024